Katt, W. P., Balkman, C. E., Butler, S. D., Byron, M., Carney, P. C., Todd-Donato, A. B., . . . Peralta, S. The MEK inhibitor trametinib is effective in inhibiting the growth of canine oral squamous cell carcinoma. Nature Portfolio.
Chicago Style (17th ed.) CitationKatt, William P., et al. The MEK Inhibitor Trametinib Is Effective in Inhibiting the Growth of Canine Oral Squamous Cell Carcinoma. Nature Portfolio.
MLA (9th ed.) CitationKatt, William P., et al. The MEK Inhibitor Trametinib Is Effective in Inhibiting the Growth of Canine Oral Squamous Cell Carcinoma. Nature Portfolio.
Warning: These citations may not always be 100% accurate.